Prostate cancer is currently the most common solid organ cancer type among men in the Western world.
Currently, all decision-making algorithms and nomograms rely on demographics, clinicopathological data and symptoms. Such an approach can easily miss significant cancers while detecting many insignificant cancers. In this review, novel functional and molecular imaging techniques used in the diagnosis and staging of localised prostate cancer and their effect on treatment decisions are discussed.
Written by:
Turkbey B, Mena E, Aras O, Garvey B, Grant K, Choyke PL. Are you the author?
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Reference: Clin Oncol (R Coll Radiol). 2013 May 27. pii: S0936-6555(13)00208-2.
doi: 10.1016/j.clon.2013.05.001
PubMed Abstract
PMID: 23722008
UroToday.com Prostate Cancer Section
